Concepedia

Effective omalizumab interval prolongation in the treatment of chronic urticaria

Mehran Alizadeh Aghdam, Rianne Henriëtte Pieterse, Petra A. Kentie, Feiko Rijken, André C. Knulst, Heike Röckmann

The Journal of Allergy and Clinical Immunology In Practice · 2020 · 19 citations · 7 references

DOIFull text

Open access

Concepts

Abstract

Funding Information: No funding was received for this work. Conflicts of interest: A. C. Knulst is a member of advisory board of Novartis; and has health care innovation grant from Novartis to institution. H. Röckmann is a member of national advisory board of Novartis. The rest of the authors declare that they have no relevant conflicts of interest.

References

7

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Torsten Zuberbier, Werner Aberer, Riccardo Asero et al. · Allergy · 2018 · 1.4K citations · Full text

, , +14

The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

Torsten Zuberbier, Werner Aberer, Riccardo Asero et al. · Allergy · 2014 · 1.2K citations

, , +14

Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control

Karsten Weller, A. Groffik, Martin K. Church et al. · Journal of Allergy and Clinical Immunology · 2014 · 412 citations · Full text

, , +3

Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria

Célia Costa, Ana Mendes, Manuel Pereira Barbosa · Allergologia et Immunopathologia · 2014 · 34 citations · Full text

, , +9

High-dose omalizumab use in patients with chronic spontaneous urticaria

Mehran Alizadeh Aghdam, Fenne van den Broek, Feiko Rijken et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 34 citations

, , +11